SPECIAL EDITION

Insurance Awareness Month is a useful moment to look at where customer demand is actually moving, rather than where the industry has traditionally sold. On that measure, the clearest signal in Indian life insurance is health. Rising medical inflation, lifestyle conditions and a growing recognition that a critical illness is a cash-flow event as much as a medical one have pushed health-linked features from add-on to central proposition.

Under the Insurance Act, 1938, life insurers in India cannot sell standalone indemnity health policies — the hospitalisation cover that reimburses room rent, surgery and treatment costs. What they can sell are health riders and benefit products: covers paying a defined amount, usually a lump sum, on diagnosis of a specified condition. That distinction is worth explaining to customers rather than blurring.

That boundary is expected to move. The pending insurance law amendment agenda includes composite licensing — a single authorisation to underwrite life, general and health business under one entity — alongside a 100% FDI limit and differential capital requirements. Until composite licences are actually issued, life insurers operate within the rider and benefit-product perimeter.

• Critical illness cover is projected as India’s fastest-growing health policy type, at roughly 17.5% compound annual growth through 2031, against ~8% for health insurance overall.

• Purchase of critical illness cover in the 35–54 age band has risen about 20%: the buyer is now mid-career, not post-retirement.

• Outpatient (OPD) benefits have gone mainstream — attachment in retail plans rose from around 5% in FY23 to the mid-teens by 2025.

• Wellness-linked pricing has moved from experiment to expectation: practitioners report close to one in ten customers funding an entire renewal premium through wellness points.

• Industry-wide, life new business premium reached ₹4.59 lakh crore in FY26, up 15.7%, with group yearly renewable premium up about 39% — partly the expansion of group health-linked riders.

With GST removed on individual life and health premiums, protection is cheaper than it has been in years — and premium growth outpacing policy growth suggests customers are buying richer cover, not just more of it.

The awareness message worth carrying

A term plan and a hospitalisation policy do not, between them, cover the income loss and non-medical costs that follow a serious diagnosis. That gap is what benefit-based health cover addresses.

A critical illness rider pays a lump sum on diagnosis of a listed condition, regardless of actual hospital bills. It is income protection, not expense reimbursement — customers should understand which problem they are solving.

Wellness engagement is no longer a marketing wrapper. Where it is priced in, it reduces cost for the customer and risk for the insurer, which is a rare alignment worth explaining clearly.

Tata AIA Life Insurance’s clearest expression of this shift is through its latest health and wellness products and offerings like – Shubh Health Criti and Sampoorna Care – Cancer with Health Buddy which includes benefits like doctor consultations, HPV vaccines and other such benefits.

The strategically interesting element is the integration with Health Buddy, Tata AIA’s wellness ecosystem covering cancer screening, health assessments and personalised tracking. 

The business context

Tata AIA reported FY26 total premium income of ₹38,164 crore, up 21%, and individual weighted new business premium of ₹10,018 crore — among the top three private life insurers on that measure. AUM stood at ₹1,45,795 crore as of 28 February 2026, up 23%. The company also reported first-place persistency in four of five cohorts; persistency, the share of policyholders who renew, is one of the better proxies for whether a product was sold appropriately.

Content in this edition was compiled from publicly available reporting and primary institutional material published between June and early September 2026, and cross-referenced across outlets before drafting.